While the rise in wound healing may be attributed to systemic causes because of increased insulin sensitivity and obesity, DNMT1 targeting was recognised as a viable treatment technique in diabetic macrophages and needs more investigation. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.